West Pharmaceutical Services Statistics Share Statistics West Pharmaceutical Services has 71.91M
shares outstanding. The number of shares has increased by -0.96%
in one year.
Shares Outstanding 71.91M Shares Change (YoY) -0.96% Shares Change (QoQ) -0.62% Owned by Institutions (%) 94.83% Shares Floating 71.45M Failed to Deliver (FTD) Shares 44 FTD / Avg. Volume 0.01%
Short Selling Information The latest short interest is 1.83M, so 2.55% of the outstanding
shares have been sold short.
Short Interest 1.83M Short % of Shares Out 2.55% Short % of Float 3.35% Short Ratio (days to cover) 3.51
Valuation Ratios The PE ratio is 48.53 and the forward
PE ratio is 32.
West Pharmaceutical Services's PEG ratio is
-3.13.
PE Ratio 48.53 Forward PE 32 PS Ratio 8.26 Forward PS 5.4 PB Ratio 8.91 P/FCF Ratio 86.51 PEG Ratio -3.13
Financial Ratio History Enterprise Valuation West Pharmaceutical Services has an Enterprise Value (EV) of 23.73B.
EV / Sales 8.2 EV / EBITDA 31.91 EV / EBIT 36.32 EV / FCF 85.86
Financial Position The company has a current ratio of 2.79,
with a Debt / Equity ratio of 0.11.
Current Ratio 2.79 Quick Ratio 2.11 Debt / Equity 0.11 Debt / EBITDA 0.41 Debt / FCF 1.1 Interest Coverage 189.97
Financial Efficiency Return on Equity is 18.37% and Return on Invested Capital is 14.94%.
Return on Equity 18.37% Return on Assets 13.52% Return on Invested Capital 14.94% Revenue Per Employee $272.94K Profits Per Employee $46.48K Employee Count 10,600 Asset Turnover 0.79 Inventory Turnover 5.03
Taxes Income Tax 107.5M Effective Tax Rate 17.91%
Stock Price Statistics The stock price has increased by -17.29% in the
last 52 weeks. The beta is 1.05, so West Pharmaceutical Services's
price volatility has been higher than the market average.
Beta 1.05 52-Week Price Change -17.29% 50-Day Moving Average 226.76 200-Day Moving Average 261.79 Relative Strength Index (RSI) 54.3 Average Volume (20 Days) 763,079
Income Statement In the last 12 months, West Pharmaceutical Services had revenue of 2.89B
and earned 492.7M
in profits. Earnings per share was 6.75.
Revenue 2.89B Gross Profit 998.5M Operating Income 569.9M Net Income 492.7M EBITDA 743.8M EBIT 588.5M Earnings Per Share (EPS) 6.75
Full Income Statement Balance Sheet The company has 484.6M in cash and 305.3M in
debt, giving a net cash position of 179.3M.
Cash & Cash Equivalents 484.6M Total Debt 305.3M Net Cash 179.3M Retained Earnings 3.96B Total Assets 3.95B Working Capital 1.08B
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 653.4M
and capital expenditures -377M, giving a free cash flow of 276.4M.
Operating Cash Flow 653.4M Capital Expenditures -377M Free Cash Flow 276.4M FCF Per Share 3.79
Full Cash Flow Statement Margins Gross margin is 34.51%, with operating and profit margins of 19.7% and 17.03%.
Gross Margin 34.51% Operating Margin 19.7% Pretax Margin 20.75% Profit Margin 17.03% EBITDA Margin 25.71% EBIT Margin 19.7% FCF Margin 9.55%
Dividends & Yields WST pays an annual dividend of $1.06,
which amounts to a dividend yield of 0.35%.
Dividend Per Share $1.06 Dividend Yield 0.35% Dividend Growth (YoY) 5% Payout Ratio 15.84% Earnings Yield 2.06% FCF Yield 1.16%
Dividend Details Analyst Forecast The average price target for WST is $350,
which is 45.6% higher than the current price. The consensus rating is "Buy".
Price Target $350 Price Target Difference 45.6% Analyst Consensus Buy Analyst Count 7
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value $51.3 Lynch Upside -78.65% Graham Number 74.7 Graham Upside -68.92%
Stock Splits The last stock split was on Sep 27, 2013. It was a
forward
split with a ratio of 2:1.
Last Split Date Sep 27, 2013 Split Type forward Split Ratio 2:1
Scores Altman Z-Score 13.2 Piotroski F-Score 8
